Healthcare | October 06, 2024
AIIMS, New organises conference on ‘Advancing Oral Health in India’
Poor oral health (periodontal disease) impacts nearly 51% of Indians
Poor oral health (periodontal disease) impacts nearly 51% of Indians
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The company will also share results in two additional posters for deuruxolitinib
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Subscribe To Our Newsletter & Stay Updated
